Tag: oncology
-
Penn Medicine Launches First Human Trial for Advanced FLASH Proton Therapy
Penn Medicine begins the first human clinical trial for FLASH proton therapy, a faster, more powerful, and potentially less-toxic radiation treatment for cancer, aiming to improve patient quality of life.
HealthScience & TechnologySportMediaMedical ScienceAstronomy and SpaceEducationEnvironmentSocial Issues Penn MedicineFLASH proton therapycancer treatmentclinical trialradiation therapyAlexander LinOncology
-
Cancer Pioneer Catherine Wu Sees Broad Promise Beyond Melanoma Breakthroughs
Pioneering cancer fighter Catherine Wu sees immense promise in oncology, urging continued research beyond melanoma breakthroughs. She describes it as a "very, very exciting time" for developing new treatments and understanding cancer.
HealthScience & TechnologyMediaEducation Catherine WuCancer researchMelanomaCancer treatmentOncologyMedical breakthroughScientific advancement
-
FDA Approves Columbia-Backed Pancreatic Cancer Drug Daraxonrasib
Daraxonrasib, a new targeted therapy supported by Columbia research, has received FDA approval for pancreatic cancer, nearly doubling overall survival in metastatic patients and marking a significant breakthrough.
HealthScience & TechnologyBusinessEducationMedical ScienceEnvironmentArtificial IntelligenceEconomySocial IssuesAsia DaraxonrasibPancreatic CancerColumbia UniversityFDAOncologyClinical TrialsDrug Approvalnewsletter
-
New Human Cancer Models to Accelerate Research and Precision Therapies
An NIH-funded international collaboration, the Human Cancer Models Initiative (HCMI), has unveiled an extensive collection of patient-derived tumor models. This resource, representing 25 cancer types, will accelerate research, deepen understanding of tumor biology, and advance precision therapies.
HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal GovernmentEducation National Institutes of HealthHuman Cancer Models InitiativeCancer ResearchPrecision TherapiesTumor ModelsOncologyMedical Research
-
Media Monitor: Cancer Diagnoses Up, Deaths Down, Washington Post Reports
The Washington Post is reporting on cancer trends, noting that while diagnoses have increased over the past 50 years, the number of deaths from the disease has decreased, according to an oncologist.
HealthMediaMedical ScienceDigital and Print Publishing CancerHealth TrendsOncologyDiagnosesMortality RatesPublic HealthWashington PostThe Washington Post
-
Experimental Drug Doubles Survival for Metastatic Pancreatic Cancer
A new experimental drug has demonstrated remarkable success, doubling the median survival rate for patients with metastatic pancreatic cancer. This breakthrough offers a dramatic shift in treatment, bringing renewed hope to those affected.
HealthBusinessScience & TechnologyEntertainmentMedical ScienceEconomyEmployment and LaborEducation Pancreatic CancerMetastatic CancerExperimental DrugCancer TreatmentMedical ResearchSurvival RateOncology
-
Yale Uncovers Wildlife Behavior Changes and New Uterine Cancer Treatment
Yale scientists reveal human impact on wildlife behavior and a new targeted chemotherapy for advanced uterine cancer. These breakthroughs highlight Yale's commitment to scientific advancement and its widespread influence.
HealthScience & TechnologyEducationMediaMedical ScienceEnvironmentLegalDigital and Print PublishingSocial Issues Yale Universitywildlifeanimal behavioroncologyuterine cancerpersonalized treatmentscientific researchUniversity
-
Sun Pharma Recalls Doxorubicin Injection Over Glass Particle Risk
Sun Pharmaceutical Industries is recalling a batch of DOXOrubicin Hydrochloride Liposome Injection in the U.S. due to potential glass particles. This recall affects 675 vials, posing risks like blood clots, though no adverse events have been reported.
HealthBusinessPolitics and GovernmentMedical ScienceLegalEducationFederal Government Product RecallPharmaceuticalsOncologyMedication SafetySun Pharmaceutical IndustriesDOXOrubicinFood RecallsFDADrugs
-
Yale Showcases Innovative Research and Unique Educational Opportunities
Yale highlights unique hands-on physics education with a particle accelerator, groundbreaking cancer research, economic history insights for policy, and initiatives fostering human connection, showcasing diverse academic and community engagement.
HealthBusinessScience & TechnologyMediaMedical ScienceEconomyEducationDigital and Print PublishingSocial Issues Yale UniversityHigher EducationPhysicsOncologyEconomicsPaul NoelLajos PusztaiUniversity